JP2012506408A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012506408A5 JP2012506408A5 JP2011532704A JP2011532704A JP2012506408A5 JP 2012506408 A5 JP2012506408 A5 JP 2012506408A5 JP 2011532704 A JP2011532704 A JP 2011532704A JP 2011532704 A JP2011532704 A JP 2011532704A JP 2012506408 A5 JP2012506408 A5 JP 2012506408A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- group
- terminus
- compound
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0819287.4A GB0819287D0 (en) | 2008-10-22 | 2008-10-22 | Compounds |
| GB0819287.4 | 2008-10-22 | ||
| PCT/GB2009/002484 WO2010046628A1 (en) | 2008-10-22 | 2009-10-20 | Compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012506408A JP2012506408A (ja) | 2012-03-15 |
| JP2012506408A5 true JP2012506408A5 (enExample) | 2012-12-06 |
| JP5820272B2 JP5820272B2 (ja) | 2015-11-24 |
Family
ID=40097772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011532704A Expired - Fee Related JP5820272B2 (ja) | 2008-10-22 | 2009-10-20 | 化合物 |
Country Status (18)
| Country | Link |
|---|---|
| US (5) | US8927486B2 (enExample) |
| EP (2) | EP2349344B1 (enExample) |
| JP (1) | JP5820272B2 (enExample) |
| CN (2) | CN104193802B (enExample) |
| CA (1) | CA2741475A1 (enExample) |
| CY (1) | CY1121309T1 (enExample) |
| DK (1) | DK2349344T5 (enExample) |
| ES (1) | ES2714590T3 (enExample) |
| GB (1) | GB0819287D0 (enExample) |
| HR (1) | HRP20190437T8 (enExample) |
| HU (1) | HUE042688T2 (enExample) |
| LT (1) | LT2349344T (enExample) |
| PL (1) | PL2349344T3 (enExample) |
| PT (1) | PT2349344T (enExample) |
| SI (1) | SI2349344T1 (enExample) |
| SM (1) | SMT201900127T1 (enExample) |
| TR (1) | TR201902884T4 (enExample) |
| WO (1) | WO2010046628A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0707034D0 (en) | 2007-04-12 | 2007-05-23 | St Andrews The | Compounds |
| GB0819287D0 (en) | 2008-10-22 | 2008-11-26 | Univ Bradford | Compounds |
| SG11201503440UA (en) | 2012-11-02 | 2015-06-29 | Heart Care Western Australia Pty Ltd | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative |
| BR112015026418B1 (pt) | 2013-04-16 | 2022-10-04 | Murray And Poole Enterprises Limited | Formulação de liberação prolongada de colchicina e uso da referida formulação de liberação prolongada de colchicina |
| GB2516882A (en) * | 2013-08-02 | 2015-02-11 | Univ Bradford | Tumour-targeted theranostic |
| KR20250051130A (ko) * | 2013-09-25 | 2025-04-16 | 싸이톰스 테라퓨틱스, 인크. | 매트릭스 메탈로프로테이나제 기질 및 다른 절단성 모이어티 및 이의 사용 방법 |
| EP3628328B1 (en) | 2014-01-31 | 2022-09-14 | Cytomx Therapeutics Inc. | Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof |
| IL300408B2 (en) | 2015-01-20 | 2025-11-01 | Cytomx Therapeutics Inc | Matrix metalloprotease-cleavable and serine protease cleavable substrates and methods of use thereof |
| GB2545169B (en) * | 2015-12-01 | 2019-10-09 | Ellipses Pharma Ltd | Taxane Prodrug Comprising A Membrane Type Matrix Metalloproteinase Cleavage Site |
| CN110358079A (zh) * | 2018-03-26 | 2019-10-22 | 鲁南制药集团股份有限公司 | 淫羊藿苷元衍生物及其制备方法和用途 |
| JP2022512124A (ja) | 2018-12-06 | 2022-02-02 | シートムエックス セラピューティクス，インコーポレイテッド | マトリックスメタロプロテアーゼ切断可能なおよびセリンまたはシステインプロテアーゼ切断可能な基質ならびにそれらの使用方法 |
| CN115353534B (zh) * | 2021-12-31 | 2024-06-07 | 郑州大学第一附属医院 | 一种秋水仙碱衍生物及其制备和其应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US819287A (en) * | 1905-09-11 | 1906-05-01 | Caesar Klaus | Automatic brake. |
| US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
| AU4583601A (en) * | 2000-03-15 | 2001-09-24 | Du Pont Pharm Co | Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use |
| GB0018240D0 (en) | 2000-07-25 | 2000-09-13 | Pharmacia & Upjohn Spa | Polymeric conjugates of antitumor agents |
| GB0105929D0 (en) | 2001-03-09 | 2001-04-25 | Btg Int Ltd | Physiologically activated prodrugs |
| ES2369542T3 (es) | 2002-07-31 | 2011-12-01 | Seattle Genetics, Inc. | Conjugados de auristatina y su uso para tratar cáncer, una enfermedad autoinmune o una enfermedad infecciosa. |
| US20050106100A1 (en) | 2003-09-03 | 2005-05-19 | Harris Thomas D. | Compounds containing matrix metalloproteinase substrates and methods of their use |
| GB0320691D0 (en) * | 2003-09-04 | 2003-10-01 | Smith & Nephew | Use of joint lining cells for articular cartilage repair |
| US8420603B2 (en) * | 2004-05-14 | 2013-04-16 | Abraxis Bioscience, Llc | SPARC and methods of use thereof |
| CA2591914C (en) | 2005-01-24 | 2017-04-25 | Board Of Regents, The University Of Texas System | Fc-fusion constructs binding to phosphatidylserine and their therapeutic use |
| US20090022782A1 (en) | 2005-02-25 | 2009-01-22 | National University Corp. Hokkaido University | Blood Retainable Device Exhibiting Selective Degradability in Tumor Tissue |
| US7714016B2 (en) * | 2005-04-08 | 2010-05-11 | Medarex, Inc. | Cytotoxic compounds and conjugates with cleavable substrates |
| GB0707034D0 (en) * | 2007-04-12 | 2007-05-23 | St Andrews The | Compounds |
| GB0819287D0 (en) | 2008-10-22 | 2008-11-26 | Univ Bradford | Compounds |
-
2008
- 2008-10-22 GB GBGB0819287.4A patent/GB0819287D0/en not_active Ceased
-
2009
- 2009-10-20 SI SI200931938T patent/SI2349344T1/sl unknown
- 2009-10-20 LT LTEP09760548.9T patent/LT2349344T/lt unknown
- 2009-10-20 CN CN201410401756.7A patent/CN104193802B/zh not_active Expired - Fee Related
- 2009-10-20 ES ES09760548T patent/ES2714590T3/es active Active
- 2009-10-20 US US13/125,732 patent/US8927486B2/en not_active Expired - Fee Related
- 2009-10-20 JP JP2011532704A patent/JP5820272B2/ja not_active Expired - Fee Related
- 2009-10-20 TR TR2019/02884T patent/TR201902884T4/tr unknown
- 2009-10-20 EP EP09760548.9A patent/EP2349344B1/en active Active
- 2009-10-20 EP EP18194638.5A patent/EP3446715A1/en not_active Withdrawn
- 2009-10-20 PL PL09760548T patent/PL2349344T3/pl unknown
- 2009-10-20 PT PT09760548T patent/PT2349344T/pt unknown
- 2009-10-20 CN CN200980141703.3A patent/CN102143762B/zh not_active Expired - Fee Related
- 2009-10-20 CA CA2741475A patent/CA2741475A1/en not_active Abandoned
- 2009-10-20 HU HUE09760548A patent/HUE042688T2/hu unknown
- 2009-10-20 SM SM20190127T patent/SMT201900127T1/it unknown
- 2009-10-20 HR HRP20190437TT patent/HRP20190437T8/hr unknown
- 2009-10-20 DK DK09760548.9T patent/DK2349344T5/en active
- 2009-10-20 WO PCT/GB2009/002484 patent/WO2010046628A1/en not_active Ceased
-
2014
- 2014-11-25 US US14/553,803 patent/US20150196658A1/en not_active Abandoned
-
2016
- 2016-10-19 US US15/297,649 patent/US9937267B2/en not_active Expired - Fee Related
-
2018
- 2018-03-01 US US15/909,475 patent/US10912839B2/en not_active Expired - Fee Related
-
2019
- 2019-02-27 CY CY20191100241T patent/CY1121309T1/el unknown
-
2020
- 2020-06-19 US US16/946,391 patent/US20200316212A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6223377B2 (ja) | 長期間作用性ペプチド類似体のための組成物 | |
| JP7175887B2 (ja) | ジスルフィド含有細胞膜透過ペプチド並びにその製造方法及び使用方法 | |
| CN103596972B (zh) | 多肽 | |
| JP5759976B2 (ja) | 位置特異的な生理活性ポリペプチド結合体の調製方法 | |
| JP2008533104A (ja) | Ｇｌｐ−１受容体の二量体ペプチドアゴニスト | |
| JP2010515686A5 (enExample) | ||
| WO2007008848A3 (en) | Monomethylvaline compounds having phenylalanine carboxy modifications at the c-terminus | |
| JP2013155195A5 (enExample) | ||
| JP2023029957A (ja) | 副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生 | |
| JP2020502051A5 (enExample) | ||
| JP2008525491A5 (enExample) | ||
| JP2013533864A5 (enExample) | ||
| JP2010502734A5 (enExample) | ||
| WO2009075859A3 (en) | Formulation of insulinotropic peptide conjugates | |
| AU2004238869A1 (en) | Novel poly(ethylene glycol) modified compounds and uses thereof | |
| JP2021520346A (ja) | 新規ｇｌｐ−１類似体 | |
| JP2006514104A5 (enExample) | ||
| JP2017534675A5 (enExample) | ||
| EP2477962A1 (en) | Prodrugs of guanfacine | |
| CA2931694C (en) | Fatty acid derivatives of dimeric peptide ligands of psd-95 and use thereof for treating excitotoxic disease | |
| CN102762586B (zh) | 治疗肽 | |
| JP2010523632A5 (enExample) | ||
| KR20230146040A (ko) | 글루카곤 유사 펩타이드-1 수용체 길항물질 | |
| AU2008339610B2 (en) | Methods of peptide modification | |
| JP2009510134A5 (enExample) |